Antiviral activity of Brazilian Green Propolis extract against SARS-CoV-2 (Severe Acute Respiratory Syndrome - Coronavirus 2) infection: case report and review.
作者信息
Fiorini Ana C, Scorza Carla A, de Almeida Antonio-Carlos G, Fonseca Marcelo C M, Finsterer Josef, Fonseca Fernando L A, Scorza Fulvio A
机构信息
Departamento de Fonoaudiologia. Escola Paulista de Medicina / Universidade Federal de Sao Paulo (EPM/UNIFESP), Sao Paulo, SP, BR. Programa de Estudos Pos-Graduado em Fonoaudiologia, Pontificia Universidade Catolica de Sao Paulo (PUC-SP), Sao Paulo, SP, BR.
Centro de Neurociencias e Saude da Mulher "Professor Geraldo Rodrigues de Lima." Escola Paulista de Medicina / Universidade Federal de Sao Paulo (EPM/UNIFESP), Sao Paulo, SP, BR.
出版信息
Clinics (Sao Paulo). 2021 Jan 22;76:e2357. doi: 10.6061/clinics/2021/e2357.
Abstract
摘要
相似文献
1
Antiviral activity of Brazilian Green Propolis extract against SARS-CoV-2 (Severe Acute Respiratory Syndrome - Coronavirus 2) infection: case report and review.巴西绿蜂胶提取物对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染的抗病毒活性：病例报告与综述
Clinics (Sao Paulo). 2021 Jan 22;76:e2357. doi: 10.6061/clinics/2021/e2357.
2
Current therapeutic options for coronavirus disease 2019 (COVID-19)-lessons learned from severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) therapy: a systematic review protocol.2019冠状病毒病（COVID-19）的当前治疗选择——从严重急性呼吸综合征（SARS）和中东呼吸综合征（MERS）治疗中吸取的经验教训：一项系统评价方案
Ann Transl Med. 2020 Nov;8(22):1527. doi: 10.21037/atm-20-2340.
3
A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.全激酶组小干扰RNA筛选鉴定出严重急性呼吸综合征冠状病毒复制中的前病毒和抗病毒宿主因子，包括双链RNA激活蛋白激酶和早期分泌途径蛋白。
J Virol. 2015 Aug;89(16):8318-33. doi: 10.1128/JVI.01029-15. Epub 2015 Jun 3.
4
A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses.严重急性呼吸综合征冠状病毒 2 与宿主抗病毒防御之间的拔河比赛：来自其他致病病毒的经验教训。
Emerg Microbes Infect. 2020 Mar 14;9(1):558-570. doi: 10.1080/22221751.2020.1736644. eCollection 2020.
5
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染：综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
6
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
7
Severe acute respiratory syndrome vs. the Middle East respiratory syndrome.严重急性呼吸综合征与中东呼吸综合征。
Curr Opin Pulm Med. 2014 May;20(3):233-41. doi: 10.1097/MCP.0000000000000046.
8
Antiviral effects of Brazilian green and red propolis extracts on Enterovirus surrogates.巴西绿蜂胶和红蜂胶提取物对肠道病毒替代物的抗病毒作用。
Environ Sci Pollut Res Int. 2020 Aug;27(23):28510-28517. doi: 10.1007/s11356-019-07458-z. Epub 2019 Dec 30.
9
A Photoactivable Natural Product with Broad Antiviral Activity against Enveloped Viruses, Including Highly Pathogenic Coronaviruses.一种光激活的天然产物，对包膜病毒具有广泛的抗病毒活性，包括高致病性冠状病毒。
Antimicrob Agents Chemother. 2022 Feb 15;66(2):e0158121. doi: 10.1128/AAC.01581-21. Epub 2021 Nov 22.
10
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.瑞德西韦是一种直接作用的抗病毒药物，能高效抑制严重急性呼吸综合征冠状病毒 2 的 RNA 依赖性 RNA 聚合酶。
J Biol Chem. 2020 May 15;295(20):6785-6797. doi: 10.1074/jbc.RA120.013679. Epub 2020 Apr 13.
引用本文的文献
1
Antiviral and anti-inflammatory efficacy of nanoencapsulated brazilian green propolis against SARS-CoV-2.纳米包封的巴西绿蜂胶对严重急性呼吸综合征冠状病毒2的抗病毒和抗炎功效
Sci Rep. 2025 Jul 1;15(1):21627. doi: 10.1038/s41598-025-05683-w.
2
Brazilian and Mexican propolis and their possible mechanism of action against non-enveloped viruses.巴西蜂胶和墨西哥蜂胶及其对抗无包膜病毒的可能作用机制。
PLoS One. 2025 May 13;20(5):e0323129. doi: 10.1371/journal.pone.0323129. eCollection 2025.
3
Antiviral Potential of Specially Selected Bulgarian Propolis Extracts: In Vitro Activity against Structurally Different Viruses.精选保加利亚蜂胶提取物的抗病毒潜力：对结构不同病毒的体外活性
Life (Basel). 2023 Jul 23;13(7):1611. doi: 10.3390/life13071611.
4
Strategies for the Management of Spike Protein-Related Pathology.刺突蛋白相关病理学的管理策略。
Microorganisms. 2023 May 17;11(5):1308. doi: 10.3390/microorganisms11051308.
5
The Effects of Propolis on Viral Respiratory Diseases.蜂胶对病毒性呼吸道疾病的影响。
Molecules. 2023 Jan 1;28(1):359. doi: 10.3390/molecules28010359.
6
Propolis: Its Role and Efficacy in Human Health and Diseases.蜂胶：在人类健康和疾病中的作用和功效。
Molecules. 2022 Sep 19;27(18):6120. doi: 10.3390/molecules27186120.
7
Perspectives for Uses of Propolis in Therapy against Infectious Diseases.蜂胶在抗感染治疗中的应用展望。
Molecules. 2022 Jul 19;27(14):4594. doi: 10.3390/molecules27144594.
8
Antimicrobial Triterpenoids and Ingol Diterpenes from Propolis of Semi-Arid Region of Morocco.半干旱地区摩洛哥蜂胶中的抗菌三萜类化合物和 Ingol 二萜类化合物。
Molecules. 2022 Mar 28;27(7):2206. doi: 10.3390/molecules27072206.
9
Evaluation of Antiviral Efficacy of a Standardized Hydroalcoholic Extract of Poplar Type Propolis Against SARS-CoV-2.杨树型蜂胶标准化水醇提取物对新型冠状病毒（SARS-CoV-2）抗病毒效果的评估
Front Microbiol. 2022 Mar 8;13:799546. doi: 10.3389/fmicb.2022.799546. eCollection 2022.
10
Potential effects of propolis and honey in COVID-19 prevention and treatment: A systematic review of in silico and clinical studies.蜂胶和蜂蜜在 COVID-19 预防和治疗中的潜在作用：基于计算机和临床研究的系统评价。
J Integr Med. 2022 Mar;20(2):114-125. doi: 10.1016/j.joim.2022.01.008. Epub 2022 Jan 31.
本文引用的文献
1
Bee products as a source of promising therapeutic and chemoprophylaxis strategies against COVID-19 (SARS-CoV-2).蜂产品作为有前景的治疗和化学预防 COVID-19（SARS-CoV-2）策略的来源。
Phytother Res. 2021 Feb;35(2):743-750. doi: 10.1002/ptr.6872. Epub 2020 Sep 18.
2
THE CHALLENGING AND UNPREDICTABLE SPECTRUM OF COVID-19 IN CHILDREN AND ADOLESCENTS.儿童和青少年中新冠病毒感染的挑战与不可预测性
Rev Paul Pediatr. 2020 Sep 7;39:e2020192. doi: 10.1590/1984-0462/2020/38/2020192.
3
Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19.蜂胶及其对 SARS-CoV-2 感染机制和 COVID-19 疾病的潜在作用：标题：蜂胶抗 SARS-CoV-2 感染和 COVID-19。
Biomed Pharmacother. 2020 Nov;131:110622. doi: 10.1016/j.biopha.2020.110622. Epub 2020 Aug 17.
4
An inflammatory cytokine signature predicts COVID-19 severity and survival.炎症细胞因子特征可预测 COVID-19 严重程度和存活情况。
Nat Med. 2020 Oct;26(10):1636-1643. doi: 10.1038/s41591-020-1051-9. Epub 2020 Aug 24.
5
Propolis and coronavirus disease 2019 (COVID-19): Lessons from nature.蜂胶与2019冠状病毒病（COVID-19）：来自大自然的启示
Complement Ther Clin Pract. 2020 Nov;41:101227. doi: 10.1016/j.ctcp.2020.101227. Epub 2020 Aug 9.
6
Current coronavirus (SARS-CoV-2) epidemiological, diagnostic and therapeutic approaches: An updated review until June 2020.当前冠状病毒（SARS-CoV-2）的流行病学、诊断和治疗方法：截至2020年6月的最新综述
EXCLI J. 2020 Jul 20;19:992-1016. doi: 10.17179/excli2020-2554. eCollection 2020.
7
SARS-CoV-2 and the pandemic of COVID-19.严重急性呼吸综合征冠状病毒 2 型和 COVID-19 大流行。
Postgrad Med J. 2021 Feb;97(1144):110-116. doi: 10.1136/postgradmedj-2020-138386. Epub 2020 Aug 11.
8
"Tomorrow Never Dies": Recent Advances in Diagnosis, Treatment, and Prevention Modalities against Coronavirus (COVID-19) amid Controversies.《明日不再来》：新冠病毒（COVID - 19）相关争议下诊断、治疗及预防方法的最新进展
Diseases. 2020 Aug 6;8(3):30. doi: 10.3390/diseases8030030.
9
Advances in research on ACE2 as a receptor for 2019-nCoV.新型冠状病毒受体 ACE2 研究进展。
Cell Mol Life Sci. 2021 Jan;78(2):531-544. doi: 10.1007/s00018-020-03611-x. Epub 2020 Aug 11.
10
Economic interventions to ameliorate the impact of COVID-19 on the economy and health: an international comparison.经济干预措施以减轻 COVID-19 对经济和健康的影响：国际比较。
J Public Health (Oxf). 2021 Apr 12;43(1):42-46. doi: 10.1093/pubmed/fdaa104.
Zotero 插件